Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.9%

9 terminated/withdrawn out of 114 trials

Success Rate

84.5%

-2.0% vs industry average

Late-Stage Pipeline

4 trials in Phase 3/4

Results Transparency

2 of 49 completed trials have results

Key Signals

29 recruiting2 with results7 terminated

Enrollment Performance

Analytics

N/A

38(50.0%)

Phase 1

19(25.0%)

Phase 2

14(18.4%)

Phase 3

3(3.9%)

Phase 4

1(1.3%)

Early Phase 1

1(1.3%)

76Total

N/A(38)

Phase 1(19)

Phase 2(14)

Phase 3(3)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (114)

Showing 20 of 114 trials

NCT03383978Phase 1Recruiting

Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma

Role: collaborator

NCT05237453Not ApplicableActive Not Recruiting

Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer

Role: collaborator

NCT07430501Not Yet Recruiting

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Role: collaborator

NCT05652361Not ApplicableRecruiting

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery

Role: collaborator

NCT05843877Phase 3Recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula

Role: collaborator

NCT05652569Recruiting

CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer

Role: lead

NCT05208710Early Phase 1Recruiting

PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers

Role: lead

NCT07148193Recruiting

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Role: collaborator

NCT07200453Not ApplicableRecruiting

Evaluation of an Interactive E-learning Environment to Enhance Digital Health Literacy in Cancer Patients

Role: collaborator

NCT04993508Not ApplicableNot Yet Recruiting

Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging

Role: collaborator

NCT04808245Phase 1Active Not Recruiting

A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas

Role: lead

NCT03396718Not ApplicableRecruiting

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

Role: collaborator

NCT05836896Phase 1Recruiting

A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell Malignancies

Role: collaborator

NCT07111884Recruiting

GMMG Multiple Myeloma Registry

Role: collaborator

NCT05690048Phase 2Recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)

Role: collaborator

NCT07033988Not Yet Recruiting

Study of Inflammatory Cells in the Blood and Cerebral Thrombus of Patients Affected by Cerebral Ischemia

Role: collaborator

NCT06614673Not ApplicableCompleted

Cancer Literacy as an Essential Factor for Lifestyle Behavior Changes: An Observational and Interventional Study